Use of pamidronate for osteoporosis treatment in public health care in Brazil
Open Access
- 1 November 2017
- journal article
- Published by Elsevier in Revista Brasileira de Reumatologia (English Edition)
- Vol. 57 (6) , 514-520
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-Term Use of Bisphosphonates in OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacyOsteoporosis International, 2008
- Pamidronate Reduces Bone Loss after Allogeneic Stem Cell TransplantationThe Journal of Clinical Endocrinology & Metabolism, 2006
- Prevention of Bone Loss after Allogeneic Stem Cell Transplantation by Calcium, Vitamin D, and Sex Hormone Replacement with or without PamidronateThe Journal of Clinical Endocrinology & Metabolism, 2005
- Pamidronate in the Prevention of Chemotherapy-Induced Bone Loss in Premenopausal Women with Breast Cancer: A Randomized Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2005
- Prevention of Bone Loss in Renal Transplant RecipientsJournal of the American Society of Nephrology, 2003
- Allogeneic Bone Marrow Transplantation is Associated with a Preferential Femoral Neck Bone LossOsteoporosis International, 2001
- Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium AloneJournal of Bone and Mineral Research, 2001
- Molecular mechanisms of action of bisphosphonatesBone, 1999
- Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantationLiver Transplantation and Surgery, 1998